Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -6 of 6 Show results per page	View Search Criteria \| Help With Results

Last Modified: 11/15/2004 First Published: 1/1/1998


1.		Phase II Study of Lutetium Texaphyrin (PCI-0123) in Photodynamic Therapy for Locally Recurrent Breast Cancer That Failed Prior Radiation Therapy (Summary Last Modified 06/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				PCI-P125-9702 NCI-V97-1314

Last Modified: 11/15/2004 First Published: 4/1/1998


2.		Phase II Study of Lutetium Texaphyrin Injection Prior to Phototherapy and with Concurrent Hormonal Therapy for Recurrent or Metastatic Breast Cancer (Summary Last Modified 01/99)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				PCI-P125-9701 NCI-V97-1315

Last Modified: 11/15/2004


3.		Phase I Study of Photodynamic Therapy with Lutetium Texaphyrin (PCI-0123) for Malignancies Accessible to Laser Illumination (Summary Last Modified 09/96)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				Pharmaceutical / Industry				PCI-P123-9501 NCI-V96-0843

Last Modified: 2/5/2007 First Published: 4/1/2000


4.		Phase I Study of Photodynamic Therapy With Lutetium Texaphyrin in Patients With Locally Recurrent Prostate Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				UPCC-6899 NCI-T99-0042, NCT00005067, T99-0042

Last Modified: 9/5/2008 First Published: 6/1/2000


5.		Phase I Study of Photodynamic Therapy With Lutetium Texaphyrin in Patients With Grade II or III Cervical Intraepithelial Neoplasia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Prevention				Completed				18 to 65				NCI				PCI-07931 NCI-T98-0066, NCT00005808, T98-0066, PCI-01-081

Last Modified: 4/20/2007 First Published: 6/23/2004


6.		Diagnostic Study of the Distribution of EF5 for the Detection of Tumor Hypoxia and Motexafin Lutetium in Patients With Intra-Abdominal Malignancies or Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic				Completed				18 and over				NCI				UPCC-04204 NCI-6508, 6508, NCT00087191

Select All on One Page